Tim Jasper Knotnerus
Tim Jasper Knotnerus has made 1 open-market purchase worth $94k since Oct 7, 2026, in 1 company. The latest: $94k of AGMB, filed Oct 7, 2026, scored 72 out of 100.
CEO, AgomAb Therapeutics NV
Follow Tim Jasper Knotnerus, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 7 Form 4 (opens sec.gov) |
AGMBAgomAb Therapeutics NV · CEOCEO · 3 insiders buying · Near 52-week low | +102% stake | 72 | $94k 11,000 at $8.58 |
−1.3% | waiting |
Track record (hypothetical): a week after the filing, these buys averaged −1.3% (0% up, 1 measured).
Questions
What stock has Tim Jasper Knotnerus bought?
AGMB (AgomAb Therapeutics NV), all on the open market and reported on SEC Form 4.
When did Tim Jasper Knotnerus last buy?
Oct 7, 2026: 11,000 shares of AGMB at $8.58, $94k in all (Form 4 (opens sec.gov)).
Has Tim Jasper Knotnerus filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Tim Jasper Knotnerus a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 7, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer